Basilea Pharmaceutica AG (SWX:BSLN)
44.60
+0.30 (0.68%)
May 13, 2025, 11:40 AM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 537.37 million as of May 13, 2025. Its market cap has increased by 8.53% in one year.
Market Cap
537.37M
Enterprise Value
528.33M
Revenue
208.54M
Ranking
n/a
PE Ratio
7.61
Stock Price
44.60
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 537.37M, an increase of 0.76%. That is a compound annual growth rate of 0.04%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 207.01B |
Novartis AG | 178.12B |
Lonza Group AG | 41.31B |
Alcon | 39.48B |
Galderma Group AG | 23.68B |
Straumann Holding AG | 17.05B |
Sandoz Group AG | 16.38B |
Sonova Holding AG | 15.62B |